Docbot is based in Irvine, Calif., and was founded in 2016. Its UltivisionAI device uses artificial intelligence to detect gastrointestinal diseases. Series A funding was provided by Khosla Ventures, Bold Capital Partners, Collaborative Fund and Boutique Venture Partners. The money raised during series A brings the company to a total of $8.5 million raised since Docbot’s inception. The additional funding will go toward clinical trials and seeking FDA clearance.
Mr. Ritter received his MBA from Philadelphia-based University of Pennsylvania and has more than 16 years of experience in GI diseases. Docbot’s founding CEO, Andrew Ninh, will continue as the company’s chief strategic officer overseeing business development, strategic partnerships and innovation.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
